BRCA1 and malignant colon neoplasm: These results suggest that the reduction of BRCA-1 expression induced by DPE/ceapinA7 or Thapsigargin/ceapinA7 combinations rendered colon cancer cells more sensitive the cytotoxic effect of Adriamycin.